Regencell Bioscience Ownership | Who Owns Regencell Bioscience?


OverviewForecastChart

Regencell Bioscience Ownership Summary


Regencell Bioscience is owned by 0.10% institutional investors, 88.55% insiders, and 11.35% retail investors. Squarepoint ops is the largest institutional shareholder, holding 0.39% of RGC shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Regencell Bioscience shares.

RGC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRegencell Bioscience0.10%88.55%11.35%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.25%11.78%67.97%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Squarepoint ops51.25K0.39%$791.80K
Discovery capital management, llc / ct46.17K0.35%$713.26K
Xtx topco38.73K0.30%$598.46K
Vident advisory18.07K0.14%$279.15K
Geode capital management413.08K0.08%$8.67M
Morgan stanley21.42K0.00%$449.90K
Ubs group18.20K0.00%$382.26K
Tower research capital llc (trc)357.000.00%$5.52K
Blackrock238.000.00%$800.00
Advisor group227.000.00%$3.27K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Discovery capital management, llc / ct46.17K0.04%$713.26K
Xtx topco38.73K0.03%$598.46K
Vident advisory18.07K0.00%$279.15K
Squarepoint ops51.25K0.00%$791.80K
Gf fund management1.06K0.00%$27.06K
Geode capital management413.08K0.00%$8.67M
Eversource wealth advisors550.000.00%$11.55K
Tower research capital llc (trc)357.000.00%$5.52K
Ronald blue trust216.000.00%$5.49K
Ubs group18.20K0.00%$382.26K

Top Buyers

HolderShares% AssetsChange
Discovery capital management, llc / ct46.17K0.04%46.17K
Xtx topco38.73K0.03%38.73K
Vident advisory18.07K0.00%18.07K
Ubs group18.20K0.00%17.82K
Gf fund management1.06K0.00%1.06K

Top Sellers

HolderShares% AssetsChange
Schonfeld strategic advisors---52.10K
Squarepoint ops51.25K0.00%-48.59K
Morgan stanley21.42K--16.42K
Y-intercept (hong kong)---13.04K
Greenfield savings bank---11.00K

New Positions

HolderShares% AssetsChangeValue
Discovery capital management, llc / ct46.17K0.04%46.17K$713.26K
Xtx topco38.73K0.03%38.73K$598.46K
Vident advisory18.07K0.00%18.07K$279.15K
Gf fund management1.06K0.00%1.06K$27.06K
Eversource wealth advisors550.000.00%550.00$11.55K

Sold Out

HolderChange
Qube research-13.00
Citigroup-70.00
Raymond james financial-71.00
Group one trading-100.00
Simplex trading-217.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202510-52.38%485,100-23.46%-0.41%6-53.85%3-40.00%
Sep 30, 20252161.54%633,811-3.78%419.01%13-5-
Jun 30, 202513160.00%691,5287731.57%5115339.76%13225.00%--100.00%
Mar 31, 2025566.67%8,830-72.02%-115.38%4100.00%1-
Dec 31, 2024350.00%31,55674.21%-1251.51%2---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index292.09K0.06%591.00
Fidelity Nasdaq Composite ETF118.88K0.02%-
L&G Asia Pacific ex Japan Equity ETF9.50K0.00%-
Amundi Prime Global ETF Dist6.99K0.00%-
TD International Equity Index ETF4.90K0.00%300.00
State Street® SPDR® S&P® China ETF4.05K0.00%-
Desjardins International Equity Idx ETF2.23K0.00%-
Amundi Prime All Country World ETF Inc1.61K0.00%-
Goldman Sachs MarketBeta Intl Eq ETF1.46K0.00%10.00
SC Global Emerg Mkt Eqs Pasv S USD1.30K0.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 29, 2017BELL THOMAS D JR-Buy$369.00K
Aug 25, 2017KAPLAN STEPHEN A-Buy$148.70K
Aug 24, 2017Ownby David EVP, CFO and TreasurerBuy$105.30K
Mar 09, 2017BRANDOW PETER B EVP, General Counsel, Sec.Sell$455.24K
Mar 09, 2017DUNN GREGORY W President and COOSell$577.01K

Insider Transactions Trends


DateBuySell
2026 Q1--
2018 Q1--
2017 Q4--
2017 Q33-
2017 Q1-2

RGC Ownership FAQ


Who Owns Regencell Bioscience?

Regencell Bioscience shareholders are primarily institutional investors at 0.10%, followed by 88.55% insiders and 11.35% retail investors. The average institutional ownership in Regencell Bioscience's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.25%, which Regencell Bioscience falls below.

Who owns the most shares of Regencell Bioscience?

Regencell Bioscience’s largest shareholders are Squarepoint ops (51.25K shares, 0.39%), Discovery capital management, llc / ct (46.17K shares, 0.35%), and Xtx topco (38.74K shares, 0.30%). Together, they hold 1.05% of Regencell Bioscience’s total shares outstanding.

Does Blackrock own Regencell Bioscience?

Yes, BlackRock owns 0.00% of Regencell Bioscience, totaling 238 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 800$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Regencell Bioscience’s biggest shareholder by percentage of total assets invested?

Discovery capital management, llc / ct is Regencell Bioscience’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 46.17K Regencell Bioscience shares, valued at 713.26K$.

Who is the top mutual fund holder of Regencell Bioscience shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Regencell Bioscience shares, with 0.06% of its total shares outstanding invested in 292.09K Regencell Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools